Showing results (1771-1780 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1997
Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline)B J Foster, L Jones, R Wiegand, et al.Investigational New Drugs|January 1, 1997
Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MSK K Chan, R Bakhtiar, C JiangInvestigational New Drugs|January 1, 1997
A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumorsN T Sklarin, C D Lathia, L Benson, et al.Investigational New Drugs|January 1, 1997
Phase II trial of topotecan in advanced gastric cancer: a Southwest Oncology Group studyJ K Benedetti, H A Burris, S P Balcerzak, et al.Investigational New Drugs|January 1, 1997
Preclinical toxicity of a new oral anticancer drug, CI-994 (acetyldinaline), in rats and dogsM J Graziano, G D Pilcher, K M Walsh, et al.Investigational New Drugs|January 1, 1997
A phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumorsR Brand, M Capadano, M TemperoInvestigational New Drugs|January 1, 1997
A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinomaW J Berg, L H Schwartz, A Amsterdam, et al.Investigational New Drugs|January 1, 1997
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)J S Macdonald, J K Benedetti, M Modiano, et al.Investigational New Drugs|January 1, 1985
Mitoxantrone as a first-line treatment of advanced breast cancerK Landys, S Borgstrom, T Andersson, et al.Investigational New Drugs|January 1, 1985
Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancerR Metz, M Delgado, R Keiling, et al.Pageof 372